Get Articles Daily from StraightStocks - Enter Email Address


  • National Debt Clock






Kraig Biocraft Laboratories, Inc. (KBLB.OB) Makes Significant Breakthrough in the Labs

Source: http://Blog.QualityStocks.net/?p=14127
Posted on Friday, December 19th, 2008 | In Small & Micro Cap
Contributed by: QualityStocks (http://QualityStocks.net) -

Earlier this month, Kraig Biocraft Laboratories announced that its scientific team, including Dr. Malcolm Fraser, Dr. Wang, Dr. Sohn, and other members, have found a process capable of doubling the number of gene transfers performed, greatly increasing productivity of the spider silk and high performance polymer development program.

Kraig Biocraft is focused on developing and commercializing high performance polymers using spider silk gene sequences. The company intends to participate in the $92 billion market for high performance and technical fibers. Last year, Kraig Biocraft Laboratories signed an intellectual property and collaborative research agreement with the University of Notre Dame and has since then been a proud sponsor of scientific research within the university.

CEO Kim K. Thompson commented, “Until recently, we were performing approximately 200 to 400 micro-injections for DNA transfer on a weekly basis. With the huge increase in brain-power that resulted from the University of Notre Dame’s addition of Dr. Wang, Dr. Sohn and other scientists to the team, we have seen a dramatic increase in both the quality and quantity of the work performed. Significantly, we are currently performing approximately 1,000 gene transfers in a single week. That puts us well ahead of our development target. Every gene transfer performed has the potential to result in the development of a new polymer or high performance fiber.”

“The new research team is proceeding in a systematic fashion to optimize the procedures to generate a good number of transgenic,” said Dr. Fraser, a member of Kraig’s Scientific Advisory Board and the head of the University of Notre Dame laboratory where the gene insertions are taking place. “Based upon what I see happening in the laboratory and with this team of scientists, I have every expectation that this is going to be a very good year,” Dr. Fraser added.

“This heightened pace,” interjected Thompson, “has been accompanied by a reformulation of the DNA inserts. The increase in productivity has been so great that instead of using a single DNA construct, we are now using multiple constructs. This is a very exciting time for the research team and Kraig.” The gene constructs are essentially packets of DNA which provide genetic instructions for

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Last 5 posts by QualityStocks





About QualityStocks (http://QualityStocks.net)

Our name, QualityStocks, emphasizes our commitment to connect subscribers with companies that have huge potential to succeed in the short and long-term future. We believe strong management and vision for the future are crucial for any company to be successful. Timing is everything and we help investors succeed by providing an objective, broad-based view of the SmallCap markets on a daily basis.

Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net

Leave a Reply

Name

Email (kept private)

Website









Related Posts

»Kraig Biocraft Laboratories, Inc. (KBLB.OB) is on the Verge of Unlocking Exciting Technology
»Kraig Biocraft Laboratories, Inc. (KBLB.OB) is Poised for Success
»Kraig Biocraft Laboratories, Inc. (KBLB.OB) is on the Cusp of Unlocking Exciting Technology

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.